We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

74 hedge funds and large institutions have $88.8M invested in Sucampo Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more capital invested

Capital invested by funds: $49.1M → $88.8M (+$39.7M)

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

7% more funds holding

Funds holding: 69 → 74 (+5)

24% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 25

93% less call options, than puts

Call options by funds: $7K | Put options by funds: $95K

Holders
74
Holders Change
+5
Holders Change %
+7.25%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
19
Reduced
25
Closed
10
Calls
$7K
Puts
$95K
Net Calls
-$88K
Net Calls Change
+$268K

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$10.7M
2
PI
Putnam Investments
Massachusetts
+$1.93M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
+$1.38M
4
BIT
BlackRock Institutional Trust
California
+$908K
5
CCM
Consonance Capital Management
New York
+$499K

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$3.19M
2
BIM
Bogle Investment Management
Massachusetts
-$761K
3
Renaissance Technologies
Renaissance Technologies
New York
-$655K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$341K
5
SO
STRS Ohio
Ohio
-$283K
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
1
Visium Asset Management
New York
$14.1M +$10.7M +1,500,000 New
GIM
2
Granahan Investment Management
Massachusetts
$11M +$190K +26,600 +2%
CCM
3
Consonance Capital Management
New York
$8.7M +$499K +70,000 +8%
BFA
4
BlackRock Fund Advisors
California
$8.04M +$62.4K +8,747 +1%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$7.62M +$29.5K +4,139 +0.5%
Vanguard Group
6
Vanguard Group
Pennsylvania
$4.67M -$341K -47,809 -9%
BIT
7
BlackRock Institutional Trust
California
$2.6M +$908K +127,268 +85%
USAA
8
United Services Automobile Association
Texas
$2.59M – – –
PI
9
Putnam Investments
Massachusetts
$2.55M +$1.93M +271,239 New
Northern Trust
10
Northern Trust
Illinois
$2.08M -$52.4K -7,352 -3%
PAMU
11
Pictet Asset Management (UK)
United Kingdom
$1.82M +$1.38M +193,500 New
State Street
12
State Street
Massachusetts
$1.68M +$2.76K +387 +0.2%
TC
13
TFS Capital
Pennsylvania
$1.4M -$134K -18,793 -11%
CCM
14
Cadence Capital Management
Massachusetts
$1.36M -$98.9K -13,860 -9%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.31M -$224K -31,453 -18%
BCM
16
Bridgeway Capital Management
Texas
$1.23M – – –
Millennium Management
17
Millennium Management
New York
$1.02M +$407K +57,024 +110%
AG
18
Algert Global
California
$939K +$256K +35,910 +56%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$881K +$200K +28,090 +43%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$801K -$133K -18,615 -18%
Wells Fargo
21
Wells Fargo
California
$765K +$73.1K +10,242 +14%
SO
22
STRS Ohio
Ohio
$758K -$283K -39,600 -33%
PM
23
Penbrook Management
New York
$655K +$497K +69,725 New
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$627K -$178K -24,900 -27%
TCIM
25
TIAA CREF Investment Management
New York
$499K – – –
1
2 3 4

SCMP Hedge Fund Activity: Q4 2013 in Review

74 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q4 2013, worth a combined $88.8M — up 81% from $49.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new SCMP positions and 10 closed out — a net gain of 5 holders — while 19 added to existing stakes and 25 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $10.7M. The largest seller was Numeric Investors, exiting entirely with an estimated $3.19M sold.

  • 74 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q4 2013, up from 69 in Q3 2013.
  • Funds reported $88.8M of Sucampo Pharmaceuticals, Inc. stock for Q4 2013, up 81% quarter-over-quarter.
  • 15 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q4 2013 and 10 closed out, a net change of +5 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q4 2013 was Visium Asset Management, an estimated $10.7M added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q4 2013 was Numeric Investors, an estimated $3.19M sold.

Based on aggregated 13F filings for Q4 2013.